跳至主要内容
临床试验/IRCT20220223054106N1
IRCT20220223054106N1尚未招募3 期

Evaluation of the effectiveness of cream containing Rhaphanus sativus seed extract in treatment of women with facial melasma - A triple blind clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Clinical diagnosis of melasma by a dermatologist (at the Center for Dermatology and Leprosy Research)
  • Female gender
  • Age of over 18 years
  • Bilateral facial melasma

排除标准

  • Pregnancy and breastfeeding
  • Use of any topical treatment for melasma during 2 months before the start of the study
  • Taking oral contraceptives and hormonal drugs for 4 weeks before the study
  • Use of drugs that increase sensitivity to sunlight; Such as doxycycline, minocycline, tetracycline, ciprofloxacin, hydrochlorothiazide and sulfonamides
  • The presence of scars, tattoos, excessive hair, or any other condition that makes the test site less likely to be evaluated

研究者

相似试验

Evaluation of the effectiveness of Raphanus sativus... | 临床试验